Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soligenix (SNGX) Cash & Equivalents (2016 - 2025)

Soligenix (SNGX) has disclosed Cash & Equivalents for 16 consecutive years, with $10.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 6.96% year-over-year to $10.5 million, compared with a TTM value of $10.5 million through Sep 2025, up 6.96%, and an annual FY2024 reading of $7.8 million, down 7.42% over the prior year.
  • Cash & Equivalents was $10.5 million for Q3 2025 at Soligenix, up from $5.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $30.5 million in Q1 2021 and bottomed at $5.1 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $15.1 million, with a median of $10.5 million recorded in 2025.
  • The sharpest move saw Cash & Equivalents skyrocketed 323.99% in 2021, then crashed 55.12% in 2023.
  • Year by year, Cash & Equivalents stood at $26.0 million in 2021, then plummeted by 48.7% to $13.4 million in 2022, then plummeted by 36.78% to $8.4 million in 2023, then fell by 7.42% to $7.8 million in 2024, then skyrocketed by 34.6% to $10.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for SNGX at $10.5 million in Q3 2025, $5.1 million in Q2 2025, and $7.3 million in Q1 2025.